nevirapine has been researched along with Atypical Mycobacterial Infection, Disseminated in 1 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Van der Ven, AJ | 1 |
| Jacobs, JA | 1 |
| Schrey, G | 1 |
1 other study available for nevirapine and Atypical Mycobacterial Infection, Disseminated
| Article | Year |
|---|---|
[Infection with Mycobacterium genavense in 2 HIV-seropositive patients in Amsterdam].
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Drug Interactio | 1998 |